CI
BPMC

Cowen Inc’s Blueprint Medicines BPMC Stock Holding History

Cowen Inc’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.08M Sell
22,000
-12,000
-35% -$990K 0.15% 110
2019
Q1 		$2.72M Sell
34,000
-1,200
-3% -$88.7K 0.29% 65
2018
Q4 		$1.9M Buy
35,200
+19,200
+120% +$1.17M 0.21% 100
2018
Q3 		$1.25M Sell
16,000
-18,000
-53% -$1.25M 0.11% 128
2018
Q2 		$2.16K Buy
+34,000
New +$2.71M 0.09% 148

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cowen Inc's BPMC Position: Q2 2019 in Review

Cowen Inc reduced its Blueprint Medicines (BPMC) stake by 35% in Q2 2019, selling an estimated $990K and leaving 22,000 shares worth $2.08M. The position accounts for 0.15% of the portfolio, ranked #110.

Cowen Inc first reported a position in BPMC in Q2 2018 and has held it in 5 quarters since. The position peaked at $2.72M in Q1 2019. 220 funds tracked by Wall St. Rank hold BPMC as of Q2 2019.

  • Cowen Inc held 22,000 shares of Blueprint Medicines worth $2.08M as of Q2 2019.
  • Cowen Inc sold 12,000 Blueprint Medicines shares in Q2 2019, an estimated $990K.
  • Blueprint Medicines made up 0.15% of Cowen Inc's portfolio in Q2 2019, its #110 holding.
  • Cowen Inc first reported a position in Blueprint Medicines in Q2 2018 and has held it in 5 quarters since.
  • Cowen Inc's Blueprint Medicines position peaked at $2.72M in Q1 2019.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.